Тёмный
Springer Healthcare IME
Springer Healthcare IME
Springer Healthcare IME
Подписаться
Bringing healthcare professionals the very latest clinical information and debate directly from the world’s leading experts.
AAIC - Discussing the potential for blood-based biomarker use
3:46
AAIC - Discussing the potential for blood-based biomarker use
19 часов назад
Enhancing Diabetes Management:Clinician-Patient Collaboration on Continuous Glucose Monitoring (CGM)
25:43
Enhancing Diabetes Management:Clinician-Patient Collaboration on Continuous Glucose Monitoring (CGM)
День назад
Episode 2: ADPD 2024™ Breakfast Bite 2 - Springer Healthcare IME: Podcast to Practice
4:03
Episode 2: ADPD 2024™ Breakfast Bite 2 - Springer Healthcare IME: Podcast to Practice
День назад
Episode 1: CONY 2024: Breakfast Bite 1 - Springer Healthcare IME: Podcast to Practice
5:06
Episode 1: CONY 2024: Breakfast Bite 1 - Springer Healthcare IME: Podcast to Practice
День назад
Episode 2: CONY 2024: Breakfast Bite 2 - Springer Healthcare IME: Podcast to Practice
10:21
Episode 2: CONY 2024: Breakfast Bite 2 - Springer Healthcare IME: Podcast to Practice
День назад
Techniques for implementing CGM in primary care | Key CGM Updates and Highlights from the ATTD 20...
25:25
Techniques for implementing CGM in primary care | Key CGM Updates and Highlights from the ATTD 20...
День назад
Key CGM Updates and Highlights from the ADA 2024 Conference | Techniques for implementing CGM in ...
18:24
Key CGM Updates and Highlights from the ADA 2024 Conference | Techniques for implementing CGM in ...
День назад
Overview of the diabetes-cardio-kidney spectrum and importance of proactive management | S5E1
9:47
Overview of the diabetes-cardio-kidney spectrum and importance of proactive management | S5E1
День назад
AAIC Conference - Breakfast Bite 7 - The effects of time on blood-based biomarkers
1:48
AAIC Conference – Breakfast Bite 7 – The effects of time on blood-based biomarkers
День назад
Targeted therapy for ALK-positive NSCLC: A practical case study | Biomarker-guided therapy in NSC...
6:28
Targeted therapy for ALK-positive NSCLC: A practical case study | Biomarker-guided therapy in NSC...
День назад
Navigating NSCLC: Merging molecular insights and targeted therapy | Biomarker-guided therapy in N...
7:18
Navigating NSCLC: Merging molecular insights and targeted therapy | Biomarker-guided therapy in N...
День назад
Optimal approaches for resectable ALK-driven NSCLC | Biomarker-guided therapy in NSCLC and beyond...
8:57
Optimal approaches for resectable ALK-driven NSCLC | Biomarker-guided therapy in NSCLC and beyond...
День назад
Improving recognition, diagnosis and classification of CKD in T2D | S5E2
14:36
Improving recognition, diagnosis and classification of CKD in T2D | S5E2
День назад
Improving integration of guidelines for CKD in T2D in clinical practice | S5E3
9:47
Improving integration of guidelines for CKD in T2D in clinical practice | S5E3
День назад
Advances in therapies that work across multiple disease disciplines | S5E4
10:23
Advances in therapies that work across multiple disease disciplines | S5E4
День назад
Optimizing care for patients with mUC
17:59
Optimizing care for patients with mUC
21 день назад
The expanding treatment landscape | Important conversations on key mUC developments
16:48
The expanding treatment landscape | Important conversations on key mUC developments
21 день назад
Advancements in Tumor-Agnostic Cancer Treatment: Expert Panel Discussion
17:25
Advancements in Tumor-Agnostic Cancer Treatment: Expert Panel Discussion
Месяц назад
New Frontiers in Oncology: Advanced Diagnostics and Therapeutics | Dr. Solange Peters
15:49
New Frontiers in Oncology: Advanced Diagnostics and Therapeutics | Dr. Solange Peters
Месяц назад
The Era of Precision Oncology | Dr. Jaime L. Schneider
19:03
The Era of Precision Oncology | Dr. Jaime L. Schneider
Месяц назад
Evolving Landscape of Targeted Therapies | Dr. Lizza Hendriks
25:06
Evolving Landscape of Targeted Therapies | Dr. Lizza Hendriks
Месяц назад
Introduction to the program
2:15
Introduction to the program
Месяц назад
CGM Updates and Highlights from ADA 2024
17:02
CGM Updates and Highlights from ADA 2024
Месяц назад
CGM Updates and Highlights from ATTD 2024
24:04
CGM Updates and Highlights from ATTD 2024
Месяц назад
Biomarker-Positive Disease: Approach to Selecting Targeted Therapies in Lung Cancer and Beyond.
1:17:22
Biomarker-Positive Disease: Approach to Selecting Targeted Therapies in Lung Cancer and Beyond.
Месяц назад
Experts in Conversation: highlights from AD/PD and CONy
36:11
Experts in Conversation: highlights from AD/PD and CONy
Месяц назад
Chapter 4 - How can we work together to expand the global center network: Q&A
14:33
Chapter 4 - How can we work together to expand the global center network: Q&A
Месяц назад
Full webcast
1:01:25
Full webcast
Месяц назад
Chapter 3: Exploring the advantages and challenges of establishing additional amyloidosis centers
27:07
Chapter 3: Exploring the advantages and challenges of establishing additional amyloidosis centers
Месяц назад
Комментарии